Physician profile
Sabitha Pabbathi
NPI 1477744498
$2,077.45
in general payments reported to CMS, 2019-2025
19 companies · $831 in 2025
The $831 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.99 · 2020: $68.29 · 2021: $32.47 · 2022: $158 · 2023: $257 · 2024: $695 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,783.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $408.34 | 2022-2025 | Apretude |
| Amgen INC. | $382.43 | 2020-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $247.09 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Gilead Sciences, INC. | $156.34 | 2023-2025 | Epclusa |
| Novo Nordisk INC | $145.68 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $97.45 | 2024 | |
| Abbott Laboratories | $91.20 | 2021-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $88.63 | 2022-2025 | Shingrix, Bexsero, Arexvy |
| Dynavax Technologies Corporation | $86.83 | 2023-2024 | Heplisav-B |
| Astrazeneca Pharmaceuticals Lp | $61.72 | 2022-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $56.33 | 2020-2023 | Rotateq, Varivax, Proquad |
| Bayer Healthcare Pharmaceuticals INC. | $54.78 | 2023-2025 | |
| Hologic Sales and Service, LLC | $51.61 | 2024-2025 | Aptima |
| Pfizer INC. | $47.01 | 2020-2024 | |
| Dexcom, INC. | $34.95 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $29.31 | 2025 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $15.12 | 2022 | |
| Sanofi-Aventis U.S. LLC | $11.61 | 2019 | |
| Organon LLC | $11.02 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sabitha Pabbathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.